Palomino Laboratories Inc.
PALX- Exchange
- OTC
- Industry
- Semiconductors & Related Devices
- SEC CIK
- 0001938569
No open-market purchases or sales by Palomino Laboratories Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Palomino Laboratories Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Palomino Laboratories Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ogawa Richard | Secretary | 1,882,500 | Aug 4, 2026 | 3 |
| Denbaars Steven | Director | 1,762,500 | Apr 20, 2026 | 2 |
| Shealy Jeffrey B. | President and CEO | 4,666,666 | Oct 27, 2025 | 1 |
| Tu Jason | Chief Accounting Officer | 125,001 | Oct 9, 2025 | 1 |
| Lucius Partners LLC | 10% Owner | 4,000,000 | Oct 2, 2025 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 20 | Same day | Ogawa RichardSecretary | PPurchase | +12.5K | $4.00 | +$50.0K | +0.7%1.76M after | |
| Apr 20, 2026 (view filing) | Apr 20 | Same day | Denbaars StevenDirector | PPurchase | +12.5K | $4.00 | +$50.0K | +0.7%1.76M after | |
| Oct 27, 2025 (view filing) | Sep 29 | 28 daysLate | Shealy Jeffrey B.President and CEO | SSale | +833.3K | $1.20 | +$1.00M | –4.67M after | Derivative |
| Oct 9, 2025 (view filing) | Sep 29 | 10 daysLate | Denbaars StevenDirector | SSale | +125.0K | $1.20 | +$150.0K | –125.0K after | Derivative |
| Oct 9, 2025 (view filing) | Sep 29 | 10 daysLate | Ogawa RichardSecretary | SSale | +125.0K | $1.20 | +$150.0K | –125.0K after | Derivative |
| Oct 9, 2025 (view filing) | Sep 29 | 10 daysLate | Tu JasonChief Accounting Officer | SSale | +41.7K | $1.20 | +$50.0K | –41.7K after | Derivative |